NYSE ARCA | ETF
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.
The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 6.12% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 5.33% |
| 6160 | Beigene Ltd | Healthcare | Biotechnology | 5.09% |
| SAN | Sanofi SA | Healthcare | Drug Manufacturers - General | 4.87% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 4.70% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.54% |
| GSK | GlaxoSmithKline PLC | Healthcare | Drug Manufacturers - General | 4.46% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 4.45% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 4.21% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 4.13% |
| 4502 | Takeda Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 4.12% |
| GMAB | Genmab A/S | Healthcare | Biotechnology | 4.12% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 4.06% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.78% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 3.78% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 3.73% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.50% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 3.48% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 3.29% |
| BCRX | BioCryst Pharmaceuticals Inc | Healthcare | Biotechnology | 2.54% |